Newsletter | July 24, 2026

07.24.26 -- STREAM Edition: Choosing The Right Metrics To Measure Process Performance

SPONSOR

 

On Demand Webinar: Reducing Particulate-Related Batch Risk in Bioprocessing: Moving from Detection to Prevention

Particulate contamination is becoming a growing regulatory and operational challenge in bioprocessing, often discovered too late to prevent costly disruptions, rework, and validation delays. In this webinar, experts explore proactive containment strategies using industry insights and real-world case patterns to identify contamination risks earlier and improve process reliability with low and ultra-low particulate container solutions. Click here to learn more.

Viral Clearance - Something Went Wrong, What Do I Do Now?

Webinar | MilliporeSigma

Even the strongest study design may encounter issues with sufficient clearance to reach the target safety expectations. Learn how to troubleshoot these and manufacturing deviations that impact viral safety.

Uncover The Intricacies Of Transposase-Mediated Genome Engineering

Webinar | ATUM

In this presentation, experts provide insight into transposase-mediated genome engineering, genetic quality control, and the maintenance of genetic stability in cell line generation.

Choosing The Right Metrics To Measure Process Performance

Video | Bioprocess Online

In this opening segment from the Bioprocess Online Live event, “The Levers And Tradeoffs That Drive Process Productivity,” panelists David Scherr, Ph.D. (AstraZeneca) and Vadim Klyushnichenko, Ph.D. (Calibr-Skaggs), discuss what metrics matter the most to evaluate productivity and measure process performance.

Development Of An Off-The-Shelf γδ T-Cell Platform

Webinar | Miltenyi Biotec

See how γδ T cells are being engineered into scalable, off-the-shelf therapies with enhanced safety and potency, as well as discover strategies to overcome immunological barriers.

The mRNA Journey: From Design To LNP-Ready Molecules For Research

Webinar | Agilent Technologies

Examine a validated, end-to-end protocol for producing high-quality in vitro transcription (IVT) mRNA for preclinical research. Find out how to optimize sequence design, small-scale synthesis, and more.

Towards A More Predictive Model Of Human Biology: A Fireside Chat

Webinar | Emulate

This presentation explores the implications of the FDA Modernization Act 2.0, the significance of predictive validity in drug discovery, the efficacy of an innovative human Liver-Chip, and more.

Connect With Bioprocess Online: